Results 31 to 40 of about 10,987 (138)

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review

open access: yesCardiology Research and Practice, 2016
Recurrent pericarditis is a complication of acute pericarditis in 20–30% of the patients and is usually idiopathic in nature. The underlying pathogenesis of this condition remains unclear, although immune-mediated mechanisms seem likely.
Shankar Baskar   +2 more
doaj   +1 more source

Recurrent pericarditis: a case report and literature review

open access: yesActa Medica Lituanica, 2017
Background. Recurrence affects about 30% (20% to 50%) of patients within 18 months after the initial episode of acute pericarditis resulting in subsequent rehospitalizations.
Justina Katinaitė   +1 more
doaj   +1 more source

Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome

open access: yesBMC Cardiovascular Disorders, 2019
Background Colchicine has been used as anti-inflammatory agent in pericardial effusion (PE). We sought to perform a meta-analysis of randomized trials assessing the efficacy and safety of colchicine in patients with pericarditis or postpericardiotomy ...
Leon L. Lutschinger   +6 more
doaj   +1 more source

Novel Pathophysiological, Diagnostic and Therapeutic Concepts in Acute and Recurrent Pericarditis

open access: yesReviews in Cardiovascular Medicine, 2023
Acute pericarditis is the most frequent pericardial disease characterized by inflammation of the pericardial layers resulting in pain, dyspnea and fatigue.
Aldo Bonaventura   +8 more
doaj   +1 more source

A risk score for pericarditis recurrence

open access: yesEuropean Journal of Clinical Investigation, 2021
AbstractBackgroundCurrently, we remain uncertain about which patients are at increased risk for recurrent pericarditis. We developed a risk score for pericarditis recurrence in patients with acute pericarditis.Materials and methodsWe prospectively recruited 262 patients with a first episode of acute pericarditis.
Emilia Lazarou   +10 more
openaire   +4 more sources

Acute and Recurrent Pericarditis

open access: yesCardiology Clinics, 2017
Acute and recurrent pericarditis is the most common pericardial syndrome encountered in clinical practice either as an isolated process or as part of a systemic disease. The diagnosis is based on clinical evaluation, electrocardiogram, and echocardiography.
Imazio M, Gaita F
openaire   +4 more sources

Idiopathic recurrent pericarditis — a paradigm shift?

open access: yesРоссийский кардиологический журнал, 2019
Idiopathic recurrent  pericarditis (IRP) is a relatively rare inflammatory disease of the pericardium,  often  requiring  emergency medical  care,   associated with a  high percentage of temporary  disability and  significant  economic  costs.
V. Yu. Myachikova   +3 more
doaj   +1 more source

Problems of immunopathology and prospects for pharmacotherapy of idiopathic recurrent pericarditis: Using an interleukin 1 inhibitor (Anakinra)

open access: yesНаучно-практическая ревматология, 2023
Pericarditis, a clinical syndrome characterized by inflammation and thickening of the pericardium, is one of the most common forms of inflammatory diseases of the cardiovascular system.
E. L. Nasonov   +3 more
doaj   +1 more source

Recurrent pericarditis after Covid-19

open access: yesReumatología Clínica (English Edition), 2022
Patient with rheumatoid arthritis who has Covid-19 with recurrent pericaditis debut, differential diagnosis.
Rodrigo Domínguez, David   +5 more
openaire   +3 more sources

The clinical course of patients with previous acute and recurrent pericarditis receiving the BNT162b2 vaccine

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2022
Background: Vaccines against SARS-COV2 have been crucial in efforts against COVID19, yet there have been reports of pericarditis following vaccination with mRNA-based vaccines.
Yishay Wasserstrum   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy